Sept. 9, 2021– Calls are increasing for the Biden administration to stop deep Medicare Part B payment cuts to many hospitals participating in the 340B drug pricing program. The reductions, which have been in place since January 2018, have been harmful for many safety-net hospitals and their patients. Earlier this summer, the administration issued proposed rules that would … [Read more...]
Congressional 340B Champion Matsui Defends Program During Hill Hearing
October 18, 2019– Rep. Doris Matsui (D-Calif.), a longtime champion of the 340B drug pricing program, defended the program during a key congressional hearing to consider drug pricing legislation. Yesterday’s House Energy & Commerce Committee meeting to mark up the Lower Drug Costs Now Act of 2019 (H.R. 3) featured the introduction of an amendment that would have limited … [Read more...]